Tim E. Emmet
Attorney, Attorney at Wyrick Robbins Yates & Ponton
About
Tim E. Emmet represents companies negotiating complex transactions in software, technology, and life sciences. His commercial contract work covers software development, pharmaceutical development and manufacturing, and intellectual property licensing. He also advises on mergers and acquisitions, venture capital, and other private financings. He joined Wyrick Robbins Yates & Ponton in 2018. He earned his J.D. from the University of Virginia School of Law. He previously worked in Cooley LLP’s emerging companies group in Washington, D.C. He later worked in-house at Patheon on general corporate, transactional, and commercial matters.
Who is a good fit for Tim E. Emmet
- Software companies pursuing acquisitions that involve development contracts or intellectual property licensing.
- Life sciences companies seeking merger or acquisition counsel with pharmaceutical development and manufacturing experience.
Education and admissions
- Education
- University of Virginia School of Law, J.D.
- James Madison University in English
- James Madison University in Economics
- Johns Hopkins University, M.A. in Applied Economics
- Bar admissions
- North Carolina, Virginia, District of Columbia
Recognition
- Listed among Business North Carolina Magazine Legal Elite: Intellectual (2026)
Specialties
Buy-side M&A representationSell-side M&A representation
Representative matters
As described on the firm’s website.
- Represented a publicly traded financial services firm in negotiations of various master service agreements, software-as-a-service agreements, license agreements, and vendor agreements.
- Represented a local investment fund in a $30 million product-based investment in a late-stage clinical biopharmaceutical program. ($30,000,000)
- Served as counsel to a publicly traded multinational pharmaceutical company in the out-licensing of an asset and the $7.5 million financing of the licensee. ($7,500,000)
- Represented a local SaaS provider in the negotiation of a multi-million dollar services agreement opposite a large publicly traded corporation.
- Represented a west-coast medical device company in the negotiation of an exclusive distributor agreement opposite a large multinational corporation.
- Served as company-side counsel to a biotechnology company in a $9 million Series A financing from strategic and venture capital investors. ($9,000,000)
- Represented a local investment fund in the sale of a royalty stream for more than $150 million. (seller side)
Deal profile
- Typical deal size
- Any deal size
- Remote work
- In-person / regional